Nrf2 Activation with Antioxidant Response Activating Nanoparticles (ARAPas) Suppresses Atherosclerosis Progression in LDLR KO Mice
Fields of Study & Subjects
Atherosclerosis and Cardiovascular Diseases
Nanoparticle-Based Drug Delivery
Cholesterol and Lipid Metabolism
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint